Literature DB >> 30098717

Gastrinomas: Medical or Surgical Treatment.

Jeffrey A Norton1, Deshka S Foster1, Tetsuhide Ito2, Robert T Jensen3.   

Abstract

This article reviews the role of surgical and medical management in patients with Zollinger-Ellison syndrome (ZES) due to a gastrin-secreting neuroendocrine tumor (gastrinoma). It concentrates on the status at present but also briefly reviews the changes over time in treatment approaches. Generally, surgical and medical therapy are complementary today; however, in some cases, such as patients with ZES and multiple endocrine neoplasia type 1, the treatment approach remains controversial. Published by Elsevier Inc.

Entities:  

Keywords:  Acid secretion; Gastrinoma; Multiple endocrine neoplasia type 1; Neuroendocrine tumor; Proton pump inhibitors; Zollinger-Ellison syndrome

Mesh：

Year:  2018        PMID： 30098717      PMCID： PMC6092039          DOI： 10.1016/j.ecl.2018.04.009

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN： 0889-8529            Impact factor:   4.741


  150 in total

1.  THE ZOLLINGER-ELLISON SYNDROME: RE-APPRAISAL AND EVALUATION OF 260 REGISTERED CASES.

Authors:  E H ELLISON; S D WILSON
Journal:  Ann Surg       Date:  1964-09       Impact factor: 12.969

2.  ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Radiological, Nuclear Medicine & Hybrid Imaging.

Authors:  Anders Sundin; Rudolf Arnold; Eric Baudin; Jaroslaw B Cwikla; Barbro Eriksson; Stefano Fanti; Nicola Fazio; Francesco Giammarile; Rodney J Hicks; Andreas Kjaer; Eric Krenning; Dik Kwekkeboom; Catherine Lombard-Bohas; Juan M O'Connor; Dermot O'Toole; Andrea Rockall; Bertram Wiedenmann; Juan W Valle; Marie-Pierre Vullierme
Journal:  Neuroendocrinology       Date:  2017-03-30       Impact factor: 4.914

3.  Is total gastrectomy still acceptable in the treatment of the Zollinger-Ellison syndrome?

Authors:  M F Brennan; A P Sloan; S R Friesen; H J Peiper; W Creutzfeldt; J C Thompson; R M Zollinger; J R Siewert
Journal:  Langenbecks Arch Chir       Date:  1986

4.  Selective venous sampling for gastrin to localize gastrinomas. A prospective assessment.

Authors:  J A Cherner; J L Doppman; J A Norton; D L Miller; A G Krudy; J P Raufman; M J Collen; P N Maton; J D Gardner; R T Jensen
Journal:  Ann Intern Med       Date:  1986-12       Impact factor: 25.391

5.  Role and Operative Technique of Portal Venous Tumor Thrombectomy in Patients with Pancreatic Neuroendocrine Tumors.

Authors:  Laura Prakash; Jeffrey E Lee; James Yao; Priya Bhosale; Aparna Balachandran; Huamin Wang; Jason B Fleming; Matthew H G Katz
Journal:  J Gastrointest Surg       Date:  2015-08-18       Impact factor: 3.452

Review 6.  Zollinger-Ellison syndrome. Current concepts in diagnosis and management.

Authors:  M M Wolfe; R T Jensen
Journal:  N Engl J Med       Date:  1987-11-05       Impact factor: 91.245

Review 7.  Apparent lymph node primary gastrinoma.

Authors:  W S Arnold; D L Fraker; H R Alexander; H C Weber; J A Norton; R T Jensen
Journal:  Surgery       Date:  1994-12       Impact factor: 3.982

8.  Role of (68)Ga-DOTATATE PET/CT in patients with multiple endocrine neoplasia type 1 (MEN1).

Authors:  Secondo Lastoria; Francesca Marciello; Antongiulio Faggiano; Luigi Aloj; Corradina Caracò; Michela Aurilio; Laura D'Ambrosio; Francesca Di Gennaro; Valeria Ramundo; Luigi Camera; Leonardo De Luca; Rosa Fonti; Vincenzo Napolitano; Annamaria Colao
Journal:  Endocrine       Date:  2015-08-05       Impact factor: 3.633

9.  Cushing's syndrome in patients with the Zollinger-Ellison syndrome.

Authors:  P N Maton; J D Gardner; R T Jensen
Journal:  N Engl J Med       Date:  1986-07-03       Impact factor: 91.245

10.  Imaging in multiple endocrine neoplasia type 1: recent studies show enhanced sensitivities but increased controversies.

Authors:  Tetsuhide Ito; Robert T Jensen
Journal:  Int J Endocr Oncol       Date:  2016-01-18
View more
  12 in total

1.  The Landmark Series: Pancreatic Neuroendocrine Tumors.

Authors:  Jordan M Cloyd; George A Poultsides
Journal:  Ann Surg Oncol       Date:  2020-09-18       Impact factor: 5.344

Review 2.  Prognostic and predictive factors on overall survival and surgical outcomes in pancreatic neuroendocrine tumors: recent advances and controversies.

Authors:  Lingaku Lee; Tetsuhide Ito; Robert T Jensen
Journal:  Expert Rev Anticancer Ther       Date:  2019-11-27       Impact factor: 4.512

3.  Hormonal tumor mapping for liver metastases of gastroenteropancreatic neuroendocrine neoplasms: a novel therapeutic strategy.

Authors:  Aya Maekawa; Atsushi Kudo; Mitsuhiro Kishino; Yoshiki Murase; Shuichi Watanabe; Yoshiya Ishikawa; Hiroki Ueda; Keiichi Akahoshi; Kosuke Ogawa; Hiroaki Ono; Shinji Tanaka; Yuko Kinowaki; Minoru Tanabe
Journal:  J Cancer Res Clin Oncol       Date:  2021-04-27       Impact factor: 4.553

4.  Perspectives on the current pharmacotherapeutic strategies for management of functional neuroendocrine tumor syndromes.

Authors:  Tetsuhide Ito; Robert T Jensen
Journal:  Expert Opin Pharmacother       Date:  2020-11-11       Impact factor: 3.889

5.  Prognostic factors and survival in MEN1 patients with gastrinomas: Results from the DutchMEN study group (DMSG).

Authors:  Dirk-Jan van Beek; Sjoerd Nell; Carolina R C Pieterman; Wouter W de Herder; Annenienke C van de Ven; Olaf M Dekkers; Anouk N van der Horst-Schrivers; Madeleine L Drent; Peter H Bisschop; Bas Havekes; Inne H M Borel Rinkes; Menno R Vriens; Gerlof D Valk
Journal:  J Surg Oncol       Date:  2019-08-10       Impact factor: 3.454

6.  Gastrinoma in multiple endocrine neoplasia type 1 after total pancreatectomy: A case report.

Authors:  Shu Gong; Zhi Li; Xu-Bao Liu; Xin Wang; Wen-Wu Shen
Journal:  Medicine (Baltimore)       Date:  2019-12       Impact factor: 1.817

Review 7.  What Are the Place and Modalities of Surgical Management for Pancreatic Neuroendocrine Neoplasms? A Narrative Review.

Authors:  Samuel Frey; Eric Mirallié; Maëlle Le Bras; Nicolas Regenet
Journal:  Cancers (Basel)       Date:  2021-11-26       Impact factor: 6.639

Review 8.  Insights into Effects/Risks of Chronic Hypergastrinemia and Lifelong PPI Treatment in Man Based on Studies of Patients with Zollinger-Ellison Syndrome.

Authors:  Lingaku Lee; Irene Ramos-Alvarez; Tetsuhide Ito; Robert T Jensen
Journal:  Int J Mol Sci       Date:  2019-10-16       Impact factor: 5.923

9.  Parathyroid surgery during the COVID-19 pandemic: Time to think about the "New Normal".

Authors:  Fábio Luiz de Menezes Montenegro; Marília D'Elboux Guimarães Brescia; Sergio Samir Arap; Marco Aurélio Valmondes Kulcsar; Marcos Roberto Tavares; Luiz Paulo Kowalski
Journal:  Clinics (Sao Paulo)       Date:  2020       Impact factor: 2.365

10.  Gastrin: From Physiology to Gastrointestinal Malignancies.

Authors:  Suzann Duan; Karen Rico; Juanita L Merchant
Journal:  Function (Oxf)       Date:  2021-11-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.